Insider Transactions in Q1 2024 at Cyteir Therapeutics, Inc. (CYT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
170,589
+4.46%
|
$341,178
$2.95 P/Share
|
|
Mar 18
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
113,777
+3.16%
|
$341,331
$3.01 P/Share
|
|
Mar 04
2024
|
Markus Md Renschler President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,304
+0.57%
|
$6,304
$1.69 P/Share
|
|
Mar 04
2024
|
David G Gaiero Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,373
+2.27%
|
$2,373
$1.69 P/Share
|
|
Feb 29
2024
|
Markus Md Renschler President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,144
+0.68%
|
$15,144
$1.45 P/Share
|
|
Feb 29
2024
|
David G Gaiero Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,985
+3.91%
|
$7,985
$1.69 P/Share
|
|
Feb 14
2024
|
Jean George Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,150
+50.0%
|
$14,150
$1.69 P/Share
|
|
Feb 09
2024
|
Stephen H. Sands Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,129
+50.0%
|
$12,129
$1.69 P/Share
|
|
Feb 08
2024
|
John F Thero Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,828
+35.98%
|
$12,828
$1.69 P/Share
|
|
Feb 06
2024
|
Joseph S Zakrzewski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,150
+5.86%
|
$14,150
$1.69 P/Share
|